US EditionTakeda Pharmaceutical (NYSE:TAK) Hits New 12-Month High – What’s Next?
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Takeda Pharmaceutical (NYSE:TAK) Hits New 12-Month High – What’s Next?
Takeda Pharmaceutical Co. (NYSE:TAK – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as $15.43 and last traded at $15.37, with a volume of 253486 shares changing hands. The stock had previously closed at $15.10. Analyst Upgrades and Downgrades Separately, Morgan Stanley upgraded […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
